The Ellison Institute of Technology combines cutting-edge research and commercial capability, to drive scientific breakthroughs and create sustainable, ethical companies.
Led by our President, Professor Sir John Bell, the distinguished immunologist and former Regius Professor of Medicine at the University of Oxford, we are bringing together cross-cutting capabilities and talent spanning synthetic biology, clinical medicine, plant science, sustainable energy, public policy, and more.
These efforts are underpinned by substantial computing capability enabled by Oracle, a world-class Artificial Intelligence team, and a Scholars programme to develop future generations of the world’s finest scientists.